15% off all orders — use code PEPTA15
HomeProductsCAG-SEMA 5

Research Use Only — Not for Human Consumption. This compound is sold exclusively for in vitro laboratory research by qualified professionals.

PeptaPeptides
CAG-SEMA 5
5 mg
99.0% PurityFor Research Use Only
RUO — Research Use Only
Not for human, veterinary, or clinical use
RUO
GLP-1

CAG-SEMA 5

Cagrilintide + Semaglutide Combination — 5 mg

(72 reviews)
99.0% Purity
$109.99per 5 mg · lyophilized

CAG-SEMA 5 is a research-grade combination product containing equal masses of cagrilintide and semaglutide in a single lyophilized preparation. The combination allows researchers to study the concurrent activation of the amylin receptor (via cagrilintide) and GLP-1 receptor (via semaglutide) — two complementary pathways that regulate appetite, gastric emptying, and glucose homeostasis through distinct mechanisms. Published combination studies have demonstrated effects beyond either compound alone in preclinical metabolic models. For research use only — not for human consumption.

3rd-Party HPLC Verified
Lot-Specific Certificate
Cold-Chain Shipping
Chemical Information
Molecular FormulaCombination preparation
Molecular WeightSee individual components
CAS NumberSee individual components
FormLyophilized Powder
Storage-20°C, dry & dark
Purity (HPLC)≥ 99.0%
Amino Acid SequenceCagrilintide + Semaglutide (1:1 ratio)
1
16 in stock
Not for Human Consumption · For Research Purposes Only
256-bit SSL
Cold-Chain Shipping
Lot-Specific CoA
ISO 9001 Facility
Independent Verification

Third-Party Tested. Every Lot.

Every batch of CAG-SEMA 5 undergoes independent HPLC and mass spectrometry analysis through an accredited third-party laboratory before it is released for sale. No exceptions. No internal-only certificates.

RP-HPLC Analysis

Every lot measured by reverse-phase HPLC. CAG-SEMA 5 consistently achieves 99.0%+ purity across batches.

ESI Mass Spec

Electrospray ionization mass spectrometry confirms exact molecular weight and rules out structural isomers or impurities.

Lot-Specific CoA

Your Certificate of Analysis references your exact lot number with actual chromatogram data — not a generic template.

Research Context

Theoretical Research Analysis

All research information below reflects published preclinical literature only. This product is not for human use, consumption, or clinical application of any kind.

Amylin + GLP-1 dual-pathway studies
Complementary appetite regulation research
Additive metabolic effect characterization
Combination peptide pharmacology

The amylin/GLP-1 combination has shown compelling synergistic effects in preclinical body weight models. Cagrilintide targets the amylin receptor in hypothalamic satiety centers, complementing semaglutide's GLP-1 receptor activity via distinct downstream signaling.

Sequence Information

Amino acid sequence:

Cagrilintide + Semaglutide (1:1 ratio)

Molecular Formula

Combination preparation

Molecular Weight

See individual components

FDA Disclaimer: The information and statements contained on this website have not been evaluated by the United States Food and Drug Administration. The products offered by PeptaPeptides LLC and the statements made herein are not intended to diagnose, treat, cure, or prevent any disease or medical condition. PeptaPeptides LLC functions solely as a chemical supplier and raw material provider. PeptaPeptides LLC is not a compounding pharmacy, nor does it constitute a chemical compounding facility as that term is defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. PeptaPeptides LLC is likewise not an outsourcing facility as defined under Section 503B of the Federal Food, Drug, and Cosmetic Act. All compounds and materials offered are provided exclusively for laboratory research, scientific analysis, and in vitro use by qualified researchers and institutions. None of the products available through PeptaPeptides LLC are intended for, approved for, or suitable for human consumption in any form.